Stay Informed: Transforming Radiology with Structured Reporting and Data-Driven Approaches

Dive into our activities, projects, and product updates. Catch on the latest industry news and learn who we are as a company and as a team.

Mint Medical showcases MSK-Prototype at IMR 2017 in Hamburg

Mint Medical was one of the sponsors of the first Intensive course Musculoskeletal Radiology (IMR) which took place on September 8th and 9th 2017 in Hamburg. It was organized by the board of the AG Bildgebende Verfahren des Bewegungsapparats. PD Dr. Marc Regier, its chairman, held the scientific lead of the event.

Besides extending its knowledge during the scientific sessions, the team of Mint Medical took the chance to showcase its prototype of a structured reading profile for the musculoskeletal system, in particular, the knee. By engaging in conversation with the IMR-participants, it was possible to collect the feedback of potential users on the reading profile as well as the corresponding mint report.

Of the 150 participants, many took the opportunity and tested the new reading profile in mint Lesion. Their feedback will help to further improve the reading profile, both from a medical as well as a usability perspective.

The team of Mint Medical wants to express its appreciation to the IMR’s organizers for the great event and to the participants for their interest in mint Lesion and their feedback on the MSK-prototype.

Related Resources

Related Resources

Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

University Hospital Munich (LMU): Study Analyzing the Tumor Growth Rate as a Prognostic Biomarker in Lymphoma Patients Under CAR T-Cell Therapy

A recent study[1] conducted by researchers at the University Hospital Munich (LMU) investigated the role of tumor growth rate (TGR) in predicting the…

Advancing Neuro-Oncology Assessments: Mint Medical to Integrate Newly Published RANO 2.0 Criteria into mint Lesion™

Glioblastomas and other gliomas are the most common malignant primary brain tumor types, yet few effective therapies are available. Clinical research…

Study Discovers Overdiagnosis of Progressive Cancer in Routine Clinical Evaluations

A recent retrospective study led by Dr. Marilyn J. Siegel and her team at the Washington University School of Medicine in St. Louis has shed light on…